Table 2 of Dejneka, Mol Vis 2008; 14:997-1005.
Percent of dosea | ||||||
Group | Sex | Sample | 6 h | 24 h | 72 h | 168 h |
1 | Males | Aqueous fluid | 0.5 | 0.4 | 0.5 | 0.05 |
1 | Males | Eye (right) | 92.1 | 46.5 | 36.9 | 8.8 |
1 | Males | Iris | 0.1 | 0.2 | 0.3 | 0.1 |
1 | Males | Retina | 0.5 | 0.9 | 2 | 2.3 |
1 | Males | Sclera (+ choroid) | 4.4 | 6 | 3.8 | 1.7 |
1 | Males | Vitreous fluid | 83.1 | 41.2 | 20 | 1.7 |
1 | Females | Aqueous fluid | 0.2 | 1.4 | 0.5 | 0.1 |
1 | Females | Eye (right) | 85.7 | 76.1 | 29.6 | 10 |
1 | Females | Iris | 0.04 | 0.2 | 0.2 | 0.2 |
1 | Females | Retina | 0.5 | 1.2 | 2.3 | 2.8 |
1 | Females | Sclera (+ choroid) | 4.5 | 4.8 | 4 | 1.3 |
1 | Females | Vitreous fluid | 82.6 | 57.1 | 18.6 | 2 |
2 | Males | Aqueous fluid | 0.9 | 1.2 | 0.9 | 0.2 |
2 | Males | Eye (right) | 91.9 | 73.2 | 51.7 | 15.8 |
2 | Males | Iris | 0.1 | 0.2 | 0.3 | 0.2 |
2 | Males | Retina | 0.3 | 0.8 | 0.9 | 1.4 |
2 | Males | Sclera (+ choroid) | 7.5 | 6.4 | 3.4 | 1.3 |
2 | Males | Vitreous fluid | 65.1 | 54 | 37.5 | 8.1 |
2 | Females | Aqueous fluid | 1.2 | 1.1 | 0.4 | 0.2 |
2 | Females | Eye (right) | 90.5 | 60.1 | 47.7 | 17.5 |
2 | Females | Iris | 0.2 | 0.2 | 0.1 | 0.2 |
2 | Females | Retina | 0.5 | 0.7 | 0.9 | 1.5 |
2 | Females | Sclera (+ choroid) | 6.6 | 5.4 | 1.7 | 1.1 |
2 | Females | Vitreous fluid | 63.2 | 50.1 | 25.1 | 10.3 |